Pauline Anderson is a journalist who writes for MDEdge and Medscape. She specializes in covering medical news and research, with a focus on topics such as epilepsy, cardiovascular health, insomnia, and other areas of interest in the field of medicine. Her work has also been featured in Knowledia.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Pauline Anderson's coverage heavily relies on cited data and focuses on medical research, cardiovascular health, neurological disorders, epilepsy, addiction, and treatment options. She appears to be interested in covering scientific findings and developments within the healthcare and pharmaceutical sectors.
To effectively reach out to Pauline with pitches or press releases, providing access to credible data or studies is crucial. This could include offering experts for commentary who have been involved in the research being covered or have expertise in related areas. Additionally, highlighting new treatment approaches or significant findings in the fields of medical research she covers may capture her attention.
Since no specific geographic focus is mentioned for Pauline's coverage area, it can be inferred that she has a broad international scope when reporting on medical research and healthcare-related topics.
This information evolves through artificial intelligence and human feedback. Improve this profile .
Los Angeles — Only about 27% of patients newly diagnosed with focal epilepsy are seizure-free on initial anti-seizure medications (ASMs), new research suggested.
LOS ANGELES — Angiotensin receptor blockers (ARB) are more effective than other antihypertensive medications in reducing the risk for post-stroke epilepsy (PSE), new research showed.
Prices of brand-name anti-seizure medications almost doubled over a recent 10-year period, whereas prices of generic versions decreased.
Prices of brand-name anti-seizure medications almost doubled over a recent 10-year period, whereas prices of generic versions decreased.
Newer glucose-lowering drugs reduce the risk for late-onset seizures and epilepsy by 24%, with GLP-1 RAs cutting the risk by 33%, new research showed.
LOS ANGELES — Newer glucose-lowering drugs reduce the risk for late-onset seizures and epilepsy by 24%, with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) cutting the risk by 33%, according to a new meta-analysis.
LOS ANGELES — The median cost of brand-name anti-seizure medications (ASMs) in the United States almost doubled from 2013 to 2023, whereas generic ASM prices declined over the same period, results of a new study showed.
By: Pauline Anderson
LOS ANGELES — Angiotensin receptor blockers are more effective than other antihypertensive medications in reducing the risk for post-stroke epilepsy (PSE), new research showed.
Researchers are gaining new insight into the relationship between the human cytomegalovirus (HCMV), a common herpes virus found in the gut, and the
Early research links the human cytomegalovirus, a type of herpes virus found in the gut, to the development of Alzheimer’s disease.
(833) 317-6278 
